These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6713632)

  • 1. Are reference limits for serum creatine kinase valid in detection of the carrier state for Duchenne muscular dystrophy?
    Gruemer HD; Miller WG; Chinchilli VM; Leshner RT; Hassler CR; Blasco PA; Nance WE; Goldsmith BM
    Clin Chem; 1984 May; 30(5):724-30. PubMed ID: 6713632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of carrier status in Duchenne dystrophy by creatine kinase measurement.
    Gruemer HD; Miller WG; Chinchilli VM; Leshner RT; Blasco PA; Hassler CR; Nance WE
    Am J Clin Pathol; 1985 Nov; 84(5):655-8. PubMed ID: 4061390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum creatine kinase in the detection of Duchenne muscular dystrophy carriers: effects of season and multiple testing.
    Percy ME; Andrews DF; Thompson MW
    Muscle Nerve; 1982 Jan; 5(1):58-64. PubMed ID: 7057807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT).
    Herrmann FH; Spiegler AW
    J Neurol Sci; 1983 Dec; 62(1-3):141-6. PubMed ID: 6668470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier testing in families of isolated cases of duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity.
    Nicholson GA; Lane RJ; Gardner-Medwin D; Walton JN
    J Neurol Sci; 1981 Jul; 51(1):29-42. PubMed ID: 7252519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of age on the detection rate in Duchenne muscular dystrophy.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):407-10. PubMed ID: 7420114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.
    Verrill HL; Pickard NA; Gruemer HD
    Clin Chem; 1977 Dec; 23(12):2341-3. PubMed ID: 923085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
    Goldsmith BM; Gruemer HD; Hawley RJ; Pickard NA; Verrill HL; Nance WE; Miller G; Crawford RG
    Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Echoscopic diagnosis of the heterozygote carrier state in Duchenne's muscular dystrophy].
    Krasil'nikov VV; Lazebnik TA; Prokof'ev GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):18-9. PubMed ID: 3066080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of serum myoglobin in neuromuscular diseases and in carrier detection of Duchenne muscular dystrophy.
    Nørregaard-Hansen K; Hein-Sørensen O
    Acta Neurol Scand; 1982 Aug; 66(2):259-66. PubMed ID: 7136489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making the most of multiple measurements in estimating carrier probability in Duchenne muscular dystrophy: the Bayesian incorporation of repeated measurements using logistic discrimination.
    Percy ME; Andrews DF; Brasher PM; Rusk AC
    Am J Med Genet; 1987 Apr; 26(4):851-61. PubMed ID: 3591827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.